Actively Recruiting
NeuroCatch Reference Interval Database
Led by HealthTech Connex Inc. · Updated on 2024-11-06
810
Participants Needed
1
Research Sites
103 weeks
Total Duration
On this page
Sponsors
H
HealthTech Connex Inc.
Lead Sponsor
N
NeuroCatch Inc.
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to understand how the brain responds to sounds and words, and how this response varies between individuals. The purpose if this study is to develop data set comparing the results from one individual with those from other members (a reference interval database of NeuroCatch® Platform 2) and to quantify the expected distribution across sex and age. NeuroCatch® Platform 2, is a medical device approved by Health Canada. The plan is to enroll 810 participants, the study includes screening for eligibility and one brain scan. The study is conducted at the Centre for Neurology Studies in Surrey, BC or at its satellite sites ( if required).
CONDITIONS
Official Title
NeuroCatch Reference Interval Database
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Any sex, 6 years of age or older
- Able to understand the consent and study procedures in English
- Willing to participate in the study
- Participants under 19 must have a parent or guardian provide consent
- Able to remain seated and focused for 7 minutes
- In good health with no history of relevant neurological illness or injury
You will not qualify if you...
- Use of hearing aids or cochlear implants, active tinnitus, or temporary hearing damage
- Unable to hear a 740Hz tone at 85dB in both ears
- Implanted pacemaker or electrical stimulators
- Metal or plastic implants in the skull (except dental/facial implants)
- Not native-level English speaker
- Prior exposure to NeuroCatch�ae audio sequences in last 3 months
- History of neurological disorders or injury (e.g., epilepsy, Parkinson's disease, brain injury)
- History of chronic pain or headache disorders
- Currently diagnosed sleeping disorders
- Diagnosed memory disorders
- History of major psychiatric disorders
- History of alcohol or substance misuse affecting brain function
- Use of medications affecting brain function
- Serious medical conditions impacting brain function
- Undergoing chemotherapy or intensive long-term therapy
- Unhealthy scalp (open wounds, bruised or weakened skin)
- Allergy to EEG gel
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Centre for Neurology Studies, 13761 96 Ave, Unit 1004
Surrey, British Columbia, Canada, V3V 0E8
Actively Recruiting
Research Team
S
Sonia Brodie
CONTACT
M
Monica Vo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here